| abstract |
The present invention refers to nitric oxide donor aspirin derivatives, a process for their preparation and pharmaceutical compositions containing -them. Formula (I) wherein R is selected from the group consisting of A) (R 0 ) t -CH (ONO 2 ) -R 2 B) (R 0 ) t - CH (ONO 2 ) - (CR 3 R 4 ) P -CH (ONO 2 ) -R 2 C) (R 0 ) t -O- (CR 3 R 4 ) n -CH (ONO 2 ) -R 2 D) (R 0 ) t -O- (CR 3 R 4 ) n -CH (ONO 2 ) - (CR 3 R 4 ) P-CH (ONO 2 ) -R 2 . |